Dr Simon Chell
Head UK Discovery Biology, AZ
Simon leads UK Discovery Biology at AstraZeneca, where he is responsible for the delivery of therapeutic programs and technological innovations through a multidisciplinary department incorporating cell sciences, biochemistry, protein sciences, functional genomics and precise genome editing. Simon has extensive experience in cancer biology and medicine creation, and a track record of delivering new therapies through innovative collaboration models. Simon has led international functions, large multidisciplinary teams and major public-private alliances in drug discovery, next generation drug formats and early clinical research.